Shanghai Minwei Biotechnology Co., Ltd
Clinical trials sponsored by Shanghai Minwei Biotechnology Co., Ltd, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Oral pill aims to keep weight off after initial loss Results expected Sep 2026 (estimated)
- Can a new injection help tackle obesity? a trial puts MWN105 to the test Results expected Oct 2026 (estimated)
- Can a new injection help people shed significant weight? Results expected Oct 2026 (estimated)
- Can one shot tame high blood pressure? Results expected Oct 2026 (estimated)
- New injection aims to tackle high cholesterol in early human trial Results expected Oct 2026 (estimated)
-
New injection MWN117 tested for safety in obesity
Disease control Not yet recruitingResearchers are testing an experimental drug called MWN117 to see if it is safe and how the body handles it. The trial enrolls 48 healthy and obese Chinese adults who receive a single injection under the skin of either MWN117 or a placebo. Participants are split into groups that …
Phase 1 • Sponsor: Shanghai Minwei Biotechnology Co., Ltd • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
Can a new injection help shed excess weight?
Disease control Not yet recruitingThis early-stage trial is testing an investigational injection called MWN110 in healthy volunteers and in people who are overweight or obese. The study aims to see if the injection is safe and tolerable, and how it affects body weight and composition. Participants receive either …
Phase 1 • Sponsor: Shanghai Minwei Biotechnology Co., Ltd • Aim: Disease control
Last updated Aug 26, 2026 00:00 UTC
-
Can a new injection help people shed significant weight?
Disease control Not yet recruitingThis phase 3 trial is testing whether an investigational injection called MWN109 can help non-diabetic adults with overweight or obesity lose weight. About 760 participants will receive either MWN109 or a placebo once a week for a year. The main goals are to see how much weight p…
Phase 3 • Sponsor: Shanghai Minwei Biotechnology Co., Ltd • Aim: Disease control
Last updated Aug 23, 2026 00:00 UTC
-
New injection aims to tackle high cholesterol in early human trial
Disease control Not yet recruitingThis early-stage trial tests a single injection of MWX205 in 37 adults with high cholesterol or blood fats (dyslipidemia). Researchers will check if the drug is safe, how the body processes it, and how it affects cholesterol levels compared to a placebo. The goal is to find the r…
Phase 1 • Sponsor: Shanghai Minwei Biotechnology Co., Ltd • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC